Css LLC Alnylam Pharmaceuticals, Inc. Transaction History

Css LLC

$1.01 Billion
Q2 2024

A detailed history of Css LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Css LLC holds 700 shares of ALNY stock, worth $194,201. This represents 0.02% of its overall portfolio holdings.

Number of Shares

700

Holding current value

$194,201

% of portfolio

0.02%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $100,317 - $172,900	700 New	700 $170,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $639,085 - $1.07 Million	4,613 New	4,613 $924,000

Others Institutions Holding ALNY

# of Institutions

641

Shares Held

108M

Call Options Held

2.11M

Put Options Held

2.04M

Capital World Investors Los Angeles, CA

15M
Shares

$4.15 Billion
0.61% of portfolio
Vanguard Group Inc Valley Forge, PA

12.5M
Shares

$3.47 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.65 Billion
0.05% of portfolio
Wellington Management Group LLP Boston, MA

6.21M
Shares

$1.72 Billion
0.28% of portfolio
Baillie Gifford & CO

4.89M
Shares

$1.36 Billion
1.03% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $34.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Account